InvaTech Pharma Solutions, LLC

FDA Regulatory Profile

InvaTech Pharma Solutions, LLC appears in FDA public data with 1 recall, 0 510(k) clearances, 3 FDA inspections, and 0 compliance actions on record. Its most recent recall (D-0115-2021, Class III) was initiated on November 11, 2020.

Summary

Total Recalls
1
510(k) Clearances
0
Inspections
3
Compliance Actions
0

Recent Recalls

NumberClassProductDate
D-0115-2021Class IIILevocetirizine Dihydrochloride Tablets, USP, 5 mg 30-count bottle, Rx Only, Distributed by: Marlex November 11, 2020